Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
- License Information
-
More Information
Article History
Received: 23 December 2024
Accepted: 2 January 2025
First Online: 26 February 2025
Conflict of interest
: M. Pühringer and F. Messner received consulting fees from Nefro Health. S. Schneeberger: relationships with commercial interests: grants/research support: Koehler Chemie, Novartis, Roche, Sandoz, Bridge to Life, Chiesi, Neovii, Organ Recovery; speaker bureau/honoraria: Astellas, Novartis, BMS, Sanofi, OrganOx, Chiesi; consulting fees: Astellas, Novartis, Teva, Sandoz, Merck, Atara, Nefro Health, ITB.
